EP Patent

EP4415701A1 — Method of administering oxybate

Assigned to Jazz Pharmaceuticals Ireland Ltd · Expires 2024-08-21 · 2y expired

What this patent protects

Provided herein are methods of administering different GHB forms on different days for the treatment of narcolepsy and other conditions.

USPTO Abstract

Provided herein are methods of administering different GHB forms on different days for the treatment of narcolepsy and other conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP4415701A1
Jurisdiction
EP
Classification
—
Expires
2024-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.